Perifere neuropathie als gevolg van vincristine bij kinderen met leukemie: een vergelijking van twee toedieningsvorme
- Conditions
- Acute lymphoblastic leukemia<br />Peripheral neuropathy<br />Vincristine<br />Chemotherapy<br />
- Registration Number
- NL-OMON29651
- Lead Sponsor
- VU University Medical Center Amsterdam
- Brief Summary
/A
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 80
Inclusion Criteria
diagnosed with pediatric ALL
- treated according to the DCOG ALL-11/ALL-12 protocol (medium and high risk patients)
Exclusion Criteria
- younger than 2 years or older than 18 years at time of diagnosis
- not able to comply with scheduled follow-up meausurements
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Peripheral neuropathy
- Secondary Outcome Measures
Name Time Method - Quality of life<br /><br>- Costs<br /><br>- Therapeutic effectiveness <br /><br>- Pharmacokinetics <br /><br>- Genotyping<br />